Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
August 03, 2023
Closing the Gap: Why Healthcare Needs More Gender Diversity in Leadership
READ MORE
July 20, 2023
Startup Exit Awards 2023: Supercomputer startup SimpleRose raises $23M to bring its technology to market
READ MORE
July 17, 2023
C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
READ MORE
July 10, 2023
Q&A with Rory Johnson, PhD
READ MORE
July 05, 2023
C4 Therapeutics Announces FDA Clearance of Investigational New Drug Application for CFT8919, an Orally Bioavailable BiDAC™ Degrader Targeting EGFR L858R for Non-Small Cell Lung Cancer
READ MORE
June 21, 2023
Small box. Big ambitions
READ MORE
June 21, 2023
Q&A with Susan Carpenter, PhD
READ MORE
June 20, 2023
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
READ MORE
June 06, 2023
Q&A with John Mattick, PhD
READ MORE
1
5
6
7
8
9
10
11
...
29
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2024 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group
